419 related articles for article (PubMed ID: 29545008)
21. Hypoactive sexual desire in women.
Kingsberg SA; Rezaee RL
Menopause; 2013 Dec; 20(12):1284-300. PubMed ID: 24219879
[TBL] [Abstract][Full Text] [Related]
22. Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women.
Rosen RC; Connor MK; Miyasato G; Link C; Shifren JL; Fisher WA; Derogatis LR; Schobelock MJ
J Womens Health (Larchmt); 2012 May; 21(5):505-15. PubMed ID: 22229714
[TBL] [Abstract][Full Text] [Related]
23. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
Anderson R; Moffatt CE
J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
[TBL] [Abstract][Full Text] [Related]
24. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Kingsberg SA; Simon JA; Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
[TBL] [Abstract][Full Text] [Related]
26. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Kingsberg SA; Althof SE
J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
[TBL] [Abstract][Full Text] [Related]
27. The presentation of hypoactive sexual desire disorder in premenopausal women.
Maserejian NN; Shifren JL; Parish SJ; Braunstein GD; Gerstenberger EP; Rosen RC
J Sex Med; 2010 Oct; 7(10):3439-48. PubMed ID: 20646184
[TBL] [Abstract][Full Text] [Related]
28. Approved hormonal treatments for HSDD: an unmet medical need.
Snabes MC; Simes SM
J Sex Med; 2009 Jul; 6(7):1846-9. PubMed ID: 19453872
[TBL] [Abstract][Full Text] [Related]
29. Endocrine aspects of female sexual dysfunction.
Davis SR; Guay AT; Shifren JL; Mazer NA
J Sex Med; 2004 Jul; 1(1):82-6. PubMed ID: 16422987
[TBL] [Abstract][Full Text] [Related]
30. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
[TBL] [Abstract][Full Text] [Related]
31. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
Robinson K; Cutler JB; Carris NW
Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
[TBL] [Abstract][Full Text] [Related]
32. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
33. Flibanserin and Female Sexual Desire.
Fantasia HC
Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
35. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
Fabre LF; Brown CS; Smith LC; Derogatis LR
J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
[TBL] [Abstract][Full Text] [Related]
36. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA; Novick AM
J Midwifery Womens Health; 2021 Nov; 66(6):740-748. PubMed ID: 34510696
[TBL] [Abstract][Full Text] [Related]
37. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
38. Flibanserin for female sexual dysfunction.
Reviriego C
Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
[TBL] [Abstract][Full Text] [Related]
39. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Clayton AH; Dennerstein L; Pyke R; Sand M
Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
[TBL] [Abstract][Full Text] [Related]
40. Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians.
Cocchetti C; Ristori J; Mazzoli F; Vignozzi L; Maggi M; Fisher AD
Int J Impot Res; 2020 Nov; 33(7):703-709. PubMed ID: 33558671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
